Resources from the same session
4878 - Next-generation sequencing (NGS) in metastatic colorectal cancer (mCRC): novel mutated genes and their effect on response to therapy (Alliance)
Presenter: Federico Innocenti
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
LBA32 - Encorafenib plus Cetuximab With or Without Binimetinib for BRAF V600E–Mutant Metastatic Colorectal Cancer: Expanded Results from a Randomized, 3-Arm, Phase III Study vs. the Choice of Either Irinotecan or FOLFIRI plus Cetuximab (BEACON CRC)
Presenter: Josep Tabernero
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
5016 - Lefitolimod vs standard of care (SOC) for patients with metastatic colorectal cancer (mCRC) responding to first-line standard treatment: Results from the randomized phase 3 IMPALA trial
Presenter: Ramon Salazar
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Gastrointestinal tumours, colorectal - Invited Discussant LBA32, LBA33 and 524O
Presenter: Alfredo Falcone
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
1890 - MIRACLE: Green tea extract versus placebo for the prevention of colorectal adenomas: a randomized, controlled trial
Presenter: Thomas Seufferlein
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast